Related Experiment Video
Updated: Jun 3, 2026
14:35
Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Secondary prevention in heart failure.
Melissa R Robinson1, Andrew E Epstein, David J Callans
1Electrophysiology Section, Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, 9 Founders Pavilion, 3400 Spruce Street, Philadelphia, PA 19104, USA.
Heart Failure Clinics
|March 29, 2011
Summary
For heart failure patients, implantable defibrillators are crucial for secondary prevention of sudden cardiac death, even with concerns about shocks. Optimal device programming can mitigate risks, but defibrillator use remains low in certain groups.
Area of Science:
- Cardiology
- Medical Devices
Background:
- Sudden cardiac death (SCD) remains a significant concern in heart failure (HF) patients.
- While primary prevention strategies are widely studied, secondary prevention using implantable cardioverter-defibrillators (ICDs) and antiarrhythmic therapy is critical for this complex group.
- Antiarrhythmic drugs are often used as adjunctive therapy with ICDs.
Purpose of the Study:
- To review the vital importance of secondary prevention strategies for sudden cardiac death in heart failure patients.
- To discuss the benefits and challenges associated with implantable defibrillators for secondary prophylaxis.
- To highlight the underutilization of defibrillators in specific patient populations.
Main Methods:
- Review of recent investigations and clinical trials focused on sudden cardiac death prevention in heart failure.
- Analysis of the role of antiarrhythmic therapy as adjuvant treatment to implantable defibrillators.
- Examination of device programming strategies for secondary prophylaxis.
Main Results:
- Secondary prophylaxis with defibrillators has demonstrated clear benefits in preventing recurrent sudden cardiac death.
- Concerns persist regarding inappropriate shocks and potential detrimental effects of appropriate shocks from defibrillators.
- Device programming can help mitigate the risks associated with defibrillator therapy.
Conclusions:
- Implantable defibrillators are essential for secondary prevention of sudden cardiac death in heart failure patients.
- Optimizing device programming is crucial for maximizing benefits and minimizing risks.
- There is a continued underuse of defibrillators in specific heart failure populations, warranting further attention.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:30Heart Failure IV: Classification and Diagnostic Evaluation
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...